Martin H. Voss, MD, on Bringing Different Disciplines Together at IKCS

Article

The medical oncologist discusses the different talks that were presented at the International Kidney Cancer Symposium in Miami.

Martin H. Voss, MD, from Memorial Sloan Kettering Cancer Center, discussed the various talks being presented at the International Kidney Cancer Symposium, held November 15-16, in Miami.

Transcription:
I’m excited to see new therapeutic strategies being discussed and I think this meeting has come a long way to actually bring different disciplines together. So, you know, we will be seeing the discussion of new targets in terms of new clinical data, but there’s also great talks that I’ve been looking forward to from laboratory investigators telling us about their efforts identifying new targets from a basic science perspective.

Related Videos
Expert on kidney cancer
Common adverse effects following treatment with lenvatinib plus pembrolizumab in the phase 3 CLEAR study include diarrhea, hypertension, and fatigue, according to Thomas E. Hutson, DO, PharmD, FACP.
Expert on kidney cancer
Expert on kidney cancer
Experts on RCC
Expert on RCC
Expert on RCC
Expert on RCC
Expert on RCC
Related Content